REA FEDERICO
Pubblicazioni
Cantarutti, A., Boracchini, R., Bellù, R., Ronco, R., Rea, F., Locatelli, A., et al. (2025). Assessing the Impact of Distance Traveled and Birth Volumes of Hospital Maternity Units on Newborn Outcomes: Population-Based Cohort Study. JMIR PUBLIC HEALTH AND SURVEILLANCE, 11 [10.2196/58944]. Dettaglio
Corrao, G., Rea, F., Iommi, M., Lallo, A., Fantaci, G., Di Martino, M., et al. (2024). Cost‐effectiveness of outpatient adherence to recommendations for monitoring of patients hospitalized for heart failure. ESC HEART FAILURE, 11(5 (October 2024)), 2719-2729 [10.1002/ehf2.14779]. Dettaglio
Pozzi, A., Cirelli, C., Merlo, A., Rea, F., Scangiuzzi, C., Tavano, E., et al. (2024). Adverse effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis. HEART FAILURE REVIEWS, 29(1), 207-217 [10.1007/s10741-023-10363-w]. Dettaglio
Ponzoni, M., Morabito, G., Corrao, G., Gerosa, G., Cantarutti, A., Rea, F. (2024). The COVID-19 Pandemic Was Associated with a Change in Therapeutic Management and Mortality in Heart Failure Patients. JOURNAL OF CLINICAL MEDICINE, 13(9) [10.3390/jcm13092625]. Dettaglio
Gregorio, C., Rea, F., Ieva, F., Scagnetto, A., Indennidate, C., Cappelletto, C., et al. (2024). Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors. VALUE IN HEALTH, 27(7), 897-906 [10.1016/j.jval.2024.03.008]. Dettaglio